Alerts will be sent to your verified email
Verify Email
GODAVARI
|
Godavari Drugs
|
Vivo Bio Tech
|
JFL Life Sciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
14.02 % | 8.25 % | 11.5 % |
|
5yr average Equity Multiplier
|
3.68 | 2.25 | 3.23 |
|
5yr Average Asset Turnover Ratio
|
1.31 | 0.54 | 0.95 |
|
5yr Avg Net Profit Margin
|
2.93 % | 6.78 % | 4.98 % |
|
Price to Book
|
1.7 | 1.2 | 0.0 |
|
P/E
|
11.61 | 10.31 | 20.25 |
|
5yr Avg Cash Conversion Cycle
|
98.79 Days | 69.38 Days | 217.93 Days |
|
Inventory Days
|
44.55 Days | 71.5 Days | 85.64 Days |
|
Days Receivable
|
136.67 Days | 97.07 Days | 186.74 Days |
|
Days Payable
|
108.22 Days | 108.42 Days | 98.82 Days |
|
5yr Average Interest Coverage Ratio
|
2.53 | 2.17 | 3.02 |
|
5yr Avg ROCE
|
20.29 % | 14.55 % | 18.94 % |
|
5yr Avg Operating Profit Margin
|
7.21 % | 35.36 % | 9.53 % |
|
5 yr average Debt to Equity
|
1.32 | 1.09 | 1.19 |
|
5yr CAGR Net Profit
|
22.65 % | -10.64 % | 55.85 % |
|
5yr Average Return on Assets
|
3.86 % | 4.02 % | 4.15 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.63 % | 40.85 % | 67.47 % |
|
Share Pledged by Promoters
|
0.25 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-3.73 % | 1.18 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Godavari Drugs
|
Vivo Bio Tech
|
JFL Life Sciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|